Phase 2b Study of  Trapsol®CycloTM for the treatment of Early Alzheimer’s Disease

Patient enrollment and site activation now underway 

Patients, family members, caregivers or patient advocates looking for additional information may email us at patients@cyclotherapeutics.com.

For any other inquiries, please see
our Contact Us page.

If you or a family member are interested in participating in our ongoing study, please visit or speak with your treating physician. You can also contact us at:
clinicaltrials@cyclotherapeutics.com.

 

Trappsol® Cyclo™ is not currently approved for any indication.

Third-party websites are provided for convenience only. Cyclo Therapeutics, Inc. does not approve of, or endorse any of the content. Cyclo Therapeutics, Inc. does not maintain, control or monitor the content of third-party websites in any way.